Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FTI Consulting Survey: 70% of Remote and Hybrid Workers Would Leave Job Over Return-to-Office Rule
-
Apogee Therapeutics to Participate in Upcoming March Investor Conferences
-
Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit
-
Alden Greenhouse Joins Electra Board of Directors
-
Liverpool City Region orders 58 next-generation Enviro400EV zero-emission double deckers from NFI subsidiary Alexander Dennis
-
REE Automotive to Host Ride & Drive of P7-C Software Defined Electric Truck at NTEA Work Truck Week 2025
-
Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome
-
Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
-
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
-
Purpose Investments Inc. Announces Final February 2025 Distribution Rate for Purpose High-Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fu
-
Kura Oncology to Participate in Three Upcoming Investor Conferences
-
RCM Technologies Expands HCM Software Services with UKG Ready Reseller Offering Empowering Small Businesses with All-In-One HCM Solutions
-
InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences
-
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution
-
REE Automotive to Host Ride & Drive of P7-C Software Defined Electric Truck at NTEA Work Truck Week 2025
-
Skyharbour Commences its 2025 Drilling Campaign with Winter Drilling Program at its Russell Lake Uranium Project, Saskatchewan
-
Cheer Holding Announces Plan to Acquire 60% Equity Stake in ZKZG, Accelerating AI Development
-
Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy
-
Historic Carnegie Hall Wedding Venue Renamed “Belle Vie,” Preserving Legacy While Embracing a Beautiful New Chapter
-
Draganfly to Present at Centurion One Capital 8th Annual Growth Conference
-
Axogen, Inc. To Host Analyst & Investor Day on March 4th
-
Axogen, Inc. To Host Analyst & Investor Day on March 4th
-
Plug Power’s Louisiana Hydrogen Plant Set for First Quarter Operations with Robust Safety Standards
-
Venus Concept Announces Senior Management Changes
-
CorVel Earns 2025 Great Place To Work Certification™
-
Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences
-
Gilat to Invest up to $3.5 Million in Disruptive ESA Based Drone Detection Startup Crosense
-
Helium Evolution Provides Significant Update on Production Facilities, Preliminary Results of 5-30 Well, and Operations Update
-
LAVA Announces Evaluation of Strategic Options
-
Nusano to Present at B. Riley Precision Oncology & Radiopharma Conference
-
LGI Homes, Inc. Reports Fourth Quarter and Full Year 2024 Results and Issues Guidance for 2025
-
Xometry Reports Fourth Quarter and Full Year 2024 Results
-
Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
-
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences
-
Aura Biosciences to Participate in Upcoming Investor Conferences
-
EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
-
PEL 83 Second Campaign – Update 5 Additional Discoveries at Mopane 3-X
-
Medicenna Reports MDNA11’s Compelling Anti-Cancer Activity is Associated with Significant Expansion of ‘Stem-Like’ Cancer Fighting Immune Cells at the Inaugural AACR-Immuno-Oncology Conference a
-
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
-
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
-
Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
-
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2024
-
Ocular Therapeutix™ to Present at Two Investor Conferences in March
-
RYVYL Announces 2024 Preliminary Revenue of $56.0 Million and Introduces 2025 Revenue Guidance of $80 Million to $90 Million
-
U.S. Department of Defense’s Defense Innovation Unit Adds Mobilicom’s SkyHopper PRO Micro to Blue UAS Framework
-
CECO Environmental Reports Fourth Quarter and Full Year 2024 Results
-
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
-
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
-
Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO
-
Bitdeer Reports Unaudited Financial Results for the Fourth Quarter and Full Year of 2024

